Common Contracts
4 similar Executive Employment Agreement contracts by Sangamo Therapeutics, Inc
EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • May 4th, 2021 • Sangamo Therapeutics, Inc • Biological products, (no disgnostic substances) • California
Employment Agreement (“Agreement”) made as of the 6th day of January 2021 by and between Sangamo Therapeutics, Inc., a Delaware corporation (the “Company”), and Robert J. Schott (“Executive”) (collectively, the “Parties”).
EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • August 5th, 2020 • Sangamo Therapeutics, Inc • Biological products, (no disgnostic substances) • California
Employment Agreement (“Agreement”) made as of the 13th day of April, 2020 by and between Sangamo Therapeutics, Inc., a Delaware corporation (the “Company”), and Mark McClung (“Executive”) (collectively, the “Parties”).
EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • February 28th, 2020 • Sangamo Therapeutics, Inc • Biological products, (no disgnostic substances) • California
Employment Agreement (“Agreement”) made as of the 21st day of October by and between Sangamo Therapeutics, Inc., a Delaware corporation (the “Company”), and Sung Lee (“Executive”) (collectively, the “Parties”).
EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • February 28th, 2020 • Sangamo Therapeutics, Inc • Biological products, (no disgnostic substances) • California
Employment Agreement (“Agreement”) made as of the 6th day of June 2019 by and between Sangamo Therapeutics, Inc., a Delaware corporation (the “Company”), and Gary Loeb (“Executive”) (collectively, the “Parties”).
